Can Effexor cause hair loss? It is a question many patients ask after noticing increased shedding whilst taking venlafaxine (branded as Efexor XL in the UK). According to the MHRA-approved Summary of Product Characteristics, alopecia is classified as an uncommon adverse reaction, potentially affecting between 1 in 100 and 1 in 1,000 users. However, the relationship between venlafaxine and hair loss is rarely straightforward — the underlying mental health condition, nutritional factors, and other medications may all play a role. This article explores what the evidence says, what to do if you notice hair thinning, and when to seek medical advice.
Summary: Venlafaxine (Effexor/Efexor XL) can cause hair loss, but it is classified as an uncommon adverse reaction, potentially affecting between 1 in 100 and 1 in 1,000 users according to the MHRA-approved Summary of Product Characteristics.
- Alopecia is listed as an 'uncommon' side effect of venlafaxine in the MHRA-approved SmPC, meaning it affects an estimated 1 in 100 to 1 in 1,000 patients.
- The likely mechanism is drug-induced telogen effluvium — a diffuse, reversible shedding that typically begins 2–3 months after starting the medication or increasing the dose.
- Hair loss in someone taking venlafaxine may be caused or worsened by the underlying depression or anxiety, iron deficiency, thyroid disorders, or other concurrent medications.
- Do not stop venlafaxine abruptly; sudden discontinuation can cause discontinuation syndrome including dizziness, nausea, and sensory disturbances.
- A GP assessment should include blood tests such as FBC, serum ferritin, and TSH to exclude treatable medical causes before attributing hair loss to venlafaxine.
- Drug-induced telogen effluvium is generally reversible, with hair regrowth typically evident within 3–6 months once the triggering factor is addressed.
Table of Contents
Am I eligible for weight loss injections?
Find out whether you might be eligible!
Answer a few quick questions to see whether you may be suitable for prescription weight loss injections (like Wegovy® or Mounjaro®).
- No commitment — just a quick suitability check
- Takes about 1 minute to complete
Does Venlafaxine (Efexor XL) Cause Hair Loss?
Venlafaxine can cause hair loss; alopecia is classified as an uncommon adverse reaction in the MHRA-approved SmPC, potentially affecting 1 in 100 to 1 in 1,000 users. The underlying condition and other factors may also contribute.
Experiencing these side effects? Our pharmacists can help you navigate them →
Venlafaxine — marketed in the UK under the brand name Efexor XL, though most prescribing is by generic name — is a serotonin-noradrenaline reuptake inhibitor (SNRI) widely used in the UK for depression, generalised anxiety disorder, social anxiety disorder, and panic disorder. One question that arises among patients starting this medication is whether venlafaxine can cause hair loss — and the short answer is: possibly, but it is not a commonly reported side effect.
Hair loss (alopecia) is classified as an uncommon adverse reaction in the Summary of Product Characteristics (SmPC) for venlafaxine prolonged-release, as approved by the Medicines and Healthcare products Regulatory Agency (MHRA). 'Uncommon' means it may affect between 1 in 100 and 1 in 1,000 users. The precise frequency category can vary slightly between individual licensed products, so it is worth checking the SmPC for the specific formulation prescribed, available via the Electronic Medicines Compendium (EMC) at medicines.org.uk.
It is important to approach this topic with balance. Many patients who notice hair thinning whilst taking venlafaxine may attribute it directly to the drug, when in reality the relationship can be more complex. The underlying condition being treated — such as depression or chronic anxiety — can itself contribute to hair loss, as can nutritional changes, stress, hormonal shifts, and other concurrent medications. That said, if you have noticed increased hair shedding since starting venlafaxine, it is worth discussing this with your GP or prescribing clinician rather than stopping the medication abruptly, as sudden discontinuation of venlafaxine carries its own risks.
If hair loss is accompanied by scalp inflammation, pain, scarring, or patchy bald areas, seek a prompt review from your GP, as these features may indicate a different underlying cause requiring separate assessment.
Not sure if this is normal? Chat with one of our pharmacists →
| Side Effect / Factor | Frequency / Likelihood | Severity | Management |
|---|---|---|---|
| Hair loss (alopecia) — venlafaxine-induced | Uncommon: 1 in 100 to 1 in 1,000 users (MHRA SmPC) | Mild to moderate; generally reversible | Speak to GP before stopping; do not discontinue abruptly |
| Drug-induced telogen effluvium | Uncommon; onset typically 2–3 months after starting or dose increase | Mild; diffuse shedding, not scarring | Regrowth usually within 3–6 months once trigger addressed |
| Iron deficiency (serum ferritin) | Common cause of hair loss, especially in women | Moderate if untreated | FBC and serum ferritin blood test; treat deficiency if confirmed |
| Thyroid disorder (hypo- or hyperthyroidism) | Common alternative cause; important to exclude | Moderate; diffuse thinning | TSH blood test; treat underlying thyroid condition |
| Underlying depression or chronic anxiety | Frequently overlooked contributor via elevated cortisol | Variable; may predate venlafaxine use | Optimise mental health treatment; do not assume drug causality |
| Other medications (e.g. lithium, valproate, beta-blockers, anticoagulants) | Variable; depends on agent and individual | Mild to moderate | Review full medication history with GP; adjust if clinically appropriate |
| Venlafaxine discontinuation syndrome | Common if stopped abruptly | Moderate to severe; dizziness, nausea, sensory disturbances | Taper dose gradually under medical supervision; never stop suddenly |
How Antidepressants May Affect Hair Growth
Antidepressants may trigger telogen effluvium by pushing hair follicles prematurely into the resting phase, causing diffuse shedding around 2–3 months after starting treatment. The precise mechanism involving serotonergic signalling in follicles remains hypothetical.
To understand why antidepressants might influence hair growth, it helps to know a little about the hair growth cycle. Hair follicles pass through three phases: anagen (active growth), catagen (transition), and telogen (resting and shedding). Disruptions to this cycle — triggered by physiological or pharmacological stressors — can push a large number of follicles prematurely into the telogen phase, resulting in diffuse shedding known as telogen effluvium.
Venlafaxine works by inhibiting the reuptake of both serotonin and noradrenaline in the brain, increasing the availability of these neurotransmitters. Serotonin receptors are present not only in the central nervous system but also in peripheral tissues, including hair follicles. Some researchers have proposed that altered serotonergic signalling may influence follicle cycling; however, it is important to note that this mechanism remains hypothetical — the precise pathway by which SNRIs or SSRIs might trigger hair loss in susceptible individuals has not been conclusively established in clinical research.
Drug-induced telogen effluvium associated with medication use typically presents as:
-
Diffuse thinning across the scalp rather than patchy bald spots
-
Increased shedding noticed on pillows, in the shower, or when brushing
-
Onset approximately 2–3 months after starting the causative agent (or following a dose increase), reflecting the natural lag in the hair cycle
Importantly, drug-induced telogen effluvium is generally reversible. Once the triggering factor is addressed — whether by adjusting the dose, switching medication under medical supervision, or allowing the body to adapt over time — hair regrowth typically becomes evident within 3–6 months. This distinguishes it from more permanent forms of alopecia. For further information on telogen effluvium, the British Association of Dermatologists (BAD) and the NHS both provide patient-facing resources.
How Common Is Hair Loss With Venlafaxine?
Hair loss is uncommon with venlafaxine, affecting an estimated 1 in 100 to 1 in 1,000 patients per the MHRA-approved SmPC. More frequently reported side effects include nausea, headache, sweating, and elevated blood pressure.
Based on the MHRA-approved SmPC for venlafaxine prolonged-release, alopecia is classified as an uncommon adverse reaction, meaning it may affect between 1 in 100 and 1 in 1,000 patients. This frequency category may vary slightly between different licensed venlafaxine products; always refer to the SmPC for the specific product prescribed.
By comparison, other side effects of venlafaxine are considerably more common. According to the NHS medicines information for venlafaxine and the British National Formulary (BNF), frequently reported adverse effects include:
-
Nausea and gastrointestinal upset (particularly in the first few weeks)
-
Headache and dizziness
-
Insomnia or somnolence
-
Increased sweating
-
Elevated blood pressure, particularly at higher doses
-
Sexual dysfunction
Hair loss sits well below these in terms of reported frequency, which means the majority of people taking venlafaxine will not experience it. However, individual susceptibility varies, and some patients may be more vulnerable due to genetic predisposition, nutritional status, or concurrent health conditions.
Post-marketing surveillance data, including spontaneous adverse event reports submitted to the MHRA's Yellow Card scheme, can help identify safety signals for infrequent reactions such as hair loss. It is important to note, however, that spontaneous reporting systems are subject to under-reporting and are not suitable for calculating precise incidence rates or establishing causality. If you believe you are experiencing hair loss as a result of venlafaxine, reporting it via the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk) contributes to ongoing pharmacovigilance and helps regulators build a more accurate picture of real-world drug safety.
What to Do If You Notice Hair Thinning on Venlafaxine
Speak to your GP or prescribing clinician before making any medication changes, as stopping venlafaxine abruptly can cause discontinuation syndrome. Your clinician may arrange blood tests, review your medication history, and consider referral to a dermatologist if needed.
If you notice increased hair shedding or thinning after starting venlafaxine, the most important first step is to speak with your GP or prescribing clinician before making any changes to your medication. Stopping venlafaxine suddenly is not recommended, as it can cause discontinuation syndrome — a cluster of symptoms including dizziness, nausea, sensory disturbances (often described as 'electric shock' sensations), and mood changes. Any dose adjustments should be made gradually and under medical supervision.
During your consultation, your clinician may wish to:
-
Review your medication history to identify any other drugs that may contribute to hair loss
-
Arrange blood tests to rule out common medical causes — first-line investigations typically include a full blood count (FBC), serum ferritin, and thyroid-stimulating hormone (TSH); testing for B12 and folate may also be considered. Testing for vitamin D or zinc is generally reserved for patients with specific risk factors or clinical features suggesting deficiency, rather than being routine
-
Assess the timeline of hair loss in relation to when venlafaxine was started or the dose was changed
-
Consider referral to a dermatologist if the hair loss is significant, progressive, does not improve after 6–12 months, or if there are features suggesting scarring alopecia, patchy hair loss (which may indicate alopecia areata), or diagnostic uncertainty
If venlafaxine is identified as the likely cause and the hair loss is distressing, your doctor may discuss switching to an alternative antidepressant. Different antidepressants carry different side effect profiles, and some patients tolerate one agent better than another. This decision must always be weighed against the therapeutic benefit of the current medication — particularly if venlafaxine is effectively managing your mental health condition.
If you are considering taking nutritional supplements, please discuss this with your clinician first. High-dose biotin (vitamin B7) supplements in particular can interfere with a range of laboratory immunoassays, including thyroid function tests, potentially leading to misleading results.
In the meantime, gentle hair care practices — avoiding excessive heat styling, tight hairstyles, and harsh chemical treatments — can help minimise additional mechanical stress on already vulnerable follicles.
Other Factors That May Contribute to Hair Loss
Hair loss in someone taking venlafaxine is often multifactorial; thyroid disorders, iron deficiency, hormonal changes, and other medications are all recognised causes that should be excluded. Treating an underlying cause may resolve hair loss without any need to change the antidepressant.
When evaluating hair loss in someone taking venlafaxine, it is essential to consider the broader clinical picture. Hair loss is a multifactorial condition, and in many cases, the medication may be only one piece of a more complex puzzle — or may not be the primary cause at all.
Mental health conditions themselves are a significant but often overlooked contributor. Both depression and chronic anxiety are associated with physiological stress responses, including elevated cortisol levels, which can disrupt the hair growth cycle and precipitate telogen effluvium. This means that hair loss may have begun before starting venlafaxine, or may be driven primarily by the underlying condition rather than the treatment.
Other common contributing factors include:
-
Thyroid disorders — both hypothyroidism and hyperthyroidism can cause diffuse hair thinning and are important to exclude with a TSH test
-
Iron deficiency — one of the most prevalent and treatable causes of hair loss, particularly in women; serum ferritin is the most sensitive marker
-
Nutritional deficiencies — deficiencies in vitamin D, zinc, or B vitamins are less commonly implicated and evidence for their role in hair loss is more limited; testing is generally recommended only where there is a clinical reason to suspect deficiency
-
Hormonal changes — such as those associated with the menopause, polycystic ovary syndrome (PCOS), or the postpartum period
-
Recent illness or physiological stress — including febrile illness (such as COVID-19), major surgery, or significant psychological stress, all of which are recognised triggers of telogen effluvium
-
Other medications — including lithium, sodium valproate and other anticonvulsants, isotretinoin, beta-blockers, anticoagulants (such as warfarin and heparins), antithyroid drugs, hormonal contraceptives, and cytotoxic chemotherapy
-
Androgenetic alopecia — the most common form of hereditary hair loss, which may become more noticeable during periods of physiological stress
A thorough assessment by your GP will help identify whether venlafaxine is genuinely implicated or whether another cause is responsible. Treating an underlying deficiency or adjusting other medications may resolve the issue without any need to change your antidepressant. Approaching hair loss as a symptom requiring investigation — rather than automatically attributing it to venlafaxine — leads to better outcomes and avoids unnecessary disruption to effective mental health treatment. The NHS and the British Association of Dermatologists (BAD) provide further guidance on the causes of hair loss and when to seek medical advice.
Frequently Asked Questions
How long after starting Effexor does hair loss begin?
Hair loss linked to venlafaxine typically begins around 2–3 months after starting the medication or after a dose increase, reflecting the natural lag in the hair growth cycle. This pattern is consistent with drug-induced telogen effluvium, where follicles are pushed prematurely into the resting phase before shedding occurs.
Will my hair grow back if Effexor is causing the hair loss?
Drug-induced telogen effluvium is generally reversible, and hair regrowth is typically evident within 3–6 months once the triggering factor is addressed. Your GP can help determine whether venlafaxine is the cause and discuss options such as dose adjustment or switching to an alternative antidepressant under medical supervision.
Is hair loss more likely with Effexor than with other antidepressants?
Hair loss is listed as an uncommon side effect across several antidepressant classes, including SSRIs and SNRIs, so no single agent is clearly more likely to cause it than another. Individual susceptibility varies, and if hair loss is a concern, your GP or psychiatrist can discuss the side effect profiles of alternative medications.
Can I take biotin supplements to help with hair loss while on venlafaxine?
You should discuss any supplements with your clinician before starting them, as high-dose biotin (vitamin B7) can interfere with laboratory immunoassays — including thyroid function tests — and potentially produce misleading results. Addressing any underlying deficiency identified through blood tests, such as low ferritin, is a more targeted approach.
What blood tests should my GP do if I'm losing hair on venlafaxine?
First-line blood tests typically include a full blood count (FBC), serum ferritin, and thyroid-stimulating hormone (TSH) to exclude iron deficiency and thyroid disorders, which are common and treatable causes of hair loss. Testing for vitamin B12, folate, vitamin D, or zinc may also be considered if there is a clinical reason to suspect deficiency.
How do I report hair loss as a side effect of venlafaxine in the UK?
You can report suspected side effects, including hair loss, directly to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk — both patients and healthcare professionals are encouraged to submit reports. Reporting helps regulators build a more accurate picture of real-world drug safety and can contribute to updated prescribing guidance.
The health-related content published on this site is based on credible scientific sources and is periodically reviewed to ensure accuracy and relevance. Although we aim to reflect the most current medical knowledge, the material is meant for general education and awareness only.
The information on this site is not a substitute for professional medical advice. For any health concerns, please speak with a qualified medical professional. By using this information, you acknowledge responsibility for any decisions made and understand we are not liable for any consequences that may result.
Any third-party brands or services referenced on this site are included for informational purposes only; we are entirely independent and have no affiliation, partnership, or collaboration with any companies mentioned.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Heading 6
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Block quote
Ordered list
- Item 1
- Item 2
- Item 3
Unordered list
- Item A
- Item B
- Item C
Bold text
Emphasis
Superscript
Subscript
